In ovarian cancer, the previous studies showed that ROS could activate various oncogenic transcription factors such as NF-κB [6], AP-1 [7], and STAT3 [8], to influence cellular transformation, tumor cell proliferation, inflammation, tumor cell survival, metastasis and invasion, and angiogenesis. This evidence concerns the gene STAT3 and neoplasm.